Study shows seladelpar beneficial for patients with primary biliary cholangitis
by Elana GotkineFor patients with primary biliary cholangitis, more receiving the peroxisome proliferator-activated receptor delta (PPARδ) agonist seladelpar have a biochemical response and alkaline p
Updated on: June 04,2024
6
Study shows seladelpar beneficial for patients with primary biliary cholangitis
by Elana GotkineFor patients with primary biliary cholangitis, more receiving the peroxisome proliferator-activated receptor delta (PPARδ) agonist seladelpar have a biochemical response and alkaline p
Updated on:June 04,2024
6